flortaucipir f-18 · Avid Radiopharms Inc · NDA 212123
Tauvid
Earliest generic entry, as listed · earliest of 2 marketed strengths
26 May 2032
Blocked by patent: US 8932557.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8932557 | substance | 26 May 2032 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 212123 · 001 · RLD · discontinued | solution, intravenous | 30ML (8.1-51mCi/ML) | 26 May 2032 |
| 212123 · 002 · RLD · discontinued | solution, intravenous | 50ML (8.1-51mCi/ML) | 26 May 2032 |
| 212123 · 003 · RLD | solution, intravenous | 50ML (8.1-100mCi/ML) | 26 May 2032 |
| 212123 · 004 · RLD | solution, intravenous | 100ML (8.1-100mCi/ML) | 26 May 2032 |